Cardiovascular disease risks in younger versus older adult B-cell non-Hodgkin’s lymphoma survivors

6Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: Young cancer survivors may be at increased risk of early-onset chronic health conditions. The aim of this population-based study is to estimate cardiovascular disease (CVD) risk among younger versus older B-cell non-Hodgkin's lymphoma (B-NHL) survivors compared with their respective general population cohorts. Methods: B-NHL survivors diagnosed from 1997 to 2015 in the Utah Cancer Registry were matched with up to five cancer-free individuals on birth year, sex, and birth state, using the statewide Utah Population Database. Electronic medical records and statewide health care facility data were used to identify disease outcomes ≥5 years after cancer diagnosis. Cox Proportional Hazards models were used to estimate hazard ratios for B-NHL survivors diagnosed at <65 years and ≥65 years old. Results: Younger B-NHL survivors had higher relative risks than older cancer survivors of chronic rheumatic disease of the heart valves (HR = 4.14, 99% CI = 2.17–7.89; P valueheterogeneity = 0.004); peri-, endo-, and myocarditis (HR = 2.43, 99% CI = 1.38–4.28; P valueheterogeneity = 0.016); diseases of the arteries (HR = 1.63, 99% CI = 1.21–2.21; P valueheterogeneity = 0.044); and hypotension (HR = 2.44, 99% CI = 1.58–3.75; P valueheterogeneity = 0.048). B-NHL survivors of both age groups had elevated relative risks of heart disease overall and congestive heart failure. Conclusion: Younger B-NHL survivors had higher risks than older B-NHL survivors of specific cardiovascular diseases compared to their respective general population cohorts.

References Powered by Scopus

Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma

2070Citations
N/AReaders
Get full text

European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma

439Citations
N/AReaders
Get full text

Acute rheumatic fever and rheumatic heart disease

420Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Age-Related Disease Risks in Younger versus Older B-Cell Non-Hodgkin’s Lymphoma Survivors

3Citations
N/AReaders
Get full text

Incident Cardiovascular Disease Risk among Older Asian, Native Hawaiian and Pacific Islander Breast Cancer Survivors

2Citations
N/AReaders
Get full text

Quality of life and late therapy effects in pediatric non-Hodgkin lymphoma survivors: Insights from a single-institution study

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ocier, K., Abdelaziz, S., Kim, S., Rowe, K., Snyder, J., Deshmukh, V., … Hashibe, M. (2021). Cardiovascular disease risks in younger versus older adult B-cell non-Hodgkin’s lymphoma survivors. Cancer Medicine, 10(12), 4117–4126. https://doi.org/10.1002/cam4.3934

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

75%

Professor / Associate Prof. 1

25%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

57%

Pharmacology, Toxicology and Pharmaceut... 1

14%

Chemistry 1

14%

Nursing and Health Professions 1

14%

Save time finding and organizing research with Mendeley

Sign up for free